- The New Geography of Innovation
- Boston-Cambridge is THE Life Sciences Hub
- Clayton Christensen Demolishes Jill Lepore’s Critique of Disruptive Innovation
- Why isn’t New York City a Biotech Hub?
- Infographic: Top 15 Large Pharma Companies by Market Cap
- Broad Institute Receives $650M for Psychiatric Research
- AbbVie will buy Shire in another Pharma tax inversion strategy
Monthly Archives: August 2013
New (and not so new) scientists often don’t think about how many digits, or significant figures they should include when reporting numerical data. Unless you’re using a finely calibrated instrument, most readings aren’t accurate beyond one or two percent (about two significant … Continue reading
Just a quick note for readers — this blog is brand new (obviously) and I’m still figuring out what I want to post and how to use the blog. So at least for now, there will be quite a random … Continue reading
The loud crickets chirping in unison tonight reminded me of A. E. Dolbear’s observation that crickets can tell you the current temperature. According to his classic 1881 communication: T = 50 + (N-40)/4 where N is the number of field cricket … Continue reading
Bruce Booth has three thought-provoking suggestions about what he’d do if he was in charge of Pharma R&D at a large company: “Invert the periphery and the core”, “Get the rest of the company out of the way of research”, … Continue reading
After two years working on my MBA, what’s three more hours in the steady rain? They say it’s good luck when it rains on the day of a wedding — so perhaps it was an auspicious end to the tenure … Continue reading
Evening falls and the sailboats are stored for the night.